indazole-3-carboxylic acid Options
Zhang et al. [81] designed and geared up three classes of multi-target inhibitors determined by the substantial sequence homology together the kinase area of angiogenic RTKs. Biological evaluation indicated that these multi-focus on inhibitors exhibited substantial prospective as novel anti-angiogeneic and anticancer brokers.Further, indazole group